Vanguard Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.7M Buy
1,052,871
+24,799
+2% +$464K ﹤0.01% 2567
2025
Q1
$18.5M Buy
1,028,072
+15,141
+1% +$272K ﹤0.01% 2541
2024
Q4
$17M Buy
1,012,931
+27,640
+3% +$465K ﹤0.01% 2661
2024
Q3
$15.9M Buy
985,291
+23,662
+2% +$383K ﹤0.01% 2712
2024
Q2
$7.9M Buy
961,629
+24,887
+3% +$205K ﹤0.01% 3042
2024
Q1
$13.9M Buy
936,742
+41,420
+5% +$613K ﹤0.01% 2782
2023
Q4
$13M Buy
895,322
+8,547
+1% +$124K ﹤0.01% 2803
2023
Q3
$9.58M Sell
886,775
-206,908
-19% -$2.23M ﹤0.01% 2913
2023
Q2
$14.1M Sell
1,093,683
-42,230
-4% -$545K ﹤0.01% 2760
2023
Q1
$15M Sell
1,135,913
-72,467
-6% -$957K ﹤0.01% 2738
2022
Q4
$18.1M Buy
1,208,380
+14,160
+1% +$212K ﹤0.01% 2667
2022
Q3
$14.1M Buy
1,194,220
+146,303
+14% +$1.73M ﹤0.01% 2787
2022
Q2
$11.8M Buy
1,047,917
+134,696
+15% +$1.52M ﹤0.01% 2900
2022
Q1
$27.3M Buy
913,221
+10,410
+1% +$311K ﹤0.01% 2607
2021
Q4
$23.9M Sell
902,811
-5,514
-0.6% -$146K ﹤0.01% 2745
2021
Q3
$33M Buy
908,325
+714
+0.1% +$25.9K ﹤0.01% 2593
2021
Q2
$39.4M Buy
907,611
+12,102
+1% +$525K ﹤0.01% 2492
2021
Q1
$30.6M Sell
895,509
-19,051
-2% -$652K ﹤0.01% 2583
2020
Q4
$32M Buy
914,560
+24,422
+3% +$855K ﹤0.01% 2413
2020
Q3
$21.4M Sell
890,138
-11,418
-1% -$274K ﹤0.01% 2425
2020
Q2
$16.5M Buy
901,556
+19,021
+2% +$348K ﹤0.01% 2517
2020
Q1
$13.8M Sell
882,535
-989
-0.1% -$15.4K ﹤0.01% 2465
2019
Q4
$18.9M Buy
883,524
+49,820
+6% +$1.07M ﹤0.01% 2560
2019
Q3
$15.6M Buy
833,704
+115,979
+16% +$2.17M ﹤0.01% 2594
2019
Q2
$18.7M Buy
717,725
+94,723
+15% +$2.47M ﹤0.01% 2536
2019
Q1
$16M Buy
623,002
+160,147
+35% +$4.12M ﹤0.01% 2603
2018
Q4
$10.6M Sell
462,855
-278,641
-38% -$6.41M ﹤0.01% 2746
2018
Q3
$23.8M Buy
741,496
+4,678
+0.6% +$150K ﹤0.01% 2502
2018
Q2
$20.9M Buy
736,818
+82,859
+13% +$2.34M ﹤0.01% 2546
2018
Q1
$23.2M Buy
653,959
+32,066
+5% +$1.14M ﹤0.01% 2442
2017
Q4
$24.1M Buy
621,893
+60,690
+11% +$2.35M ﹤0.01% 2421
2017
Q3
$14.3M Sell
561,203
-42,776
-7% -$1.09M ﹤0.01% 2644
2017
Q2
$16.5M Buy
603,979
+34,875
+6% +$952K ﹤0.01% 2542
2017
Q1
$18.8M Buy
569,104
+96,035
+20% +$3.18M ﹤0.01% 2467
2016
Q4
$11.3M Sell
473,069
-12,685
-3% -$302K ﹤0.01% 2695
2016
Q3
$17.8M Buy
485,754
+23,529
+5% +$864K ﹤0.01% 2414
2016
Q2
$10.3M Buy
462,225
+11,919
+3% +$266K ﹤0.01% 2635
2016
Q1
$9.37M Buy
450,306
+108,296
+32% +$2.25M ﹤0.01% 2646
2015
Q4
$10.4M Buy
342,010
+15,427
+5% +$467K ﹤0.01% 2618
2015
Q3
$8.07M Buy
326,583
+9,912
+3% +$245K ﹤0.01% 2718
2015
Q2
$10.2M Buy
316,671
+8,979
+3% +$288K ﹤0.01% 2664
2015
Q1
$11M Buy
307,692
+8,237
+3% +$294K ﹤0.01% 2600
2014
Q4
$6.8M Sell
299,455
-73,124
-20% -$1.66M ﹤0.01% 2733
2014
Q3
$7.23M Sell
372,579
-39,149
-10% -$759K ﹤0.01% 2648
2014
Q2
$14.9M Buy
411,728
+410
+0.1% +$14.9K ﹤0.01% 2333
2014
Q1
$16M Buy
411,318
+34,124
+9% +$1.32M ﹤0.01% 2274
2013
Q4
$10.8M Sell
377,194
-102,292
-21% -$2.92M ﹤0.01% 2429
2013
Q3
$17.2M Buy
479,486
+23,711
+5% +$849K ﹤0.01% 2171
2013
Q2
$15.2M Buy
+455,775
New +$15.2M ﹤0.01% 2154